[
    {
        "data": {
            "description": "Process of drug development from first-in-human (FIH) to regulatory submission for approval, including the different phases of clinical development, role of biomarkers and companion diagnostics in clinical trials, and chemistry, manufacturing, and controls of drug product. Discussion of clinical development of different modalities, including small molecules and protein therapeutics.",
            "id": "PHMSCI 763",
            "parent": "PHMSCI",
            "title": "THE DRUG DEVELOPMENT PROCESS II"
        }
    },
    {
        "data": {
            "id": "PHMSCI",
            "type": "compound"
        }
    }
]